Results of surgical treatment of patients with stage IV colon cancer of older age groups and ways to improve them

Abstract

The effectiveness of cytoreductive operations in geriatric patients with stage IV colon cancer was assessed. A comparative analysis of the results of surgical treatment of metastatic colon cancer in patients of various age groups was carried out. The molecular biological properties of colon adenocarcinoma in patients with metastatic colorectal cancer were studied. The clinical significance of immunohistochemical markers as the proliferative index of stem cancer cells (ALDH+Ki-67+) and the chemokine receptor CXCR4 was determined for predicting the long-term results of surgical treatment of patients with stage IV colon cancer has been determined. It was found that the survival rates of elderly and senile patients are not inferior to those in patients under 60 years of age. A comparative analysis of the immediate and long-term results of treatment indicates the effectiveness of cytoreductive interventions in elderly and senile patients suffering from stage IV colon cancer. It was found that the expression level of the receptor for CXCR4 chemokines and the proliferative activity of stem cancer cells correlate with the life expectancy of patients after cytoreductive interventions and can be used to clarify the indications for their implementation.

Keywords

cytoreductive surgery / colon adenocarcinoma / metastatic cancer / elderly and senile patients / molecular biological properties of the tumor / immunohistochemical diagnosis / prognostic significance

References

[1] Афанасьев, С.Г. Циторедуктивные операции (нужно ли удалять первичную опухоль? Где предел разумной циторедукции?) / С.Г. Афанасьев, А.Ю. Добродеев // Практ. онкология. –2014. – Т. 15, № 2. – С. 93– 95.

[2] Патютко, Ю.И. Диагностика и лечение метастазов колоректального рака в печени / Ю.И. Патютко, А.В. Пылев // Росс. мед. журнал. – 2009. – № 22. – С. 1505.

[3] Раскин, Г.А. Клинико-морфологическая оценка прогностических и предиктивных факторов при аденокарциноме толстой кишки: дис. … д-ра мед. наук / Г.А. Раскин. – СПб., 2015. – 238 с.

[4] Сазонов, А.А. Гериатрические аспекты в онкоколопроктологии / А.А. Сазонов, Н.А. Майстренко // Успехи геронтологии. – 2016. – Т. 29, № 2. – С. 269–274.

[5] Audisio, R.A. Treatment of colorectal cancer in older patients / R.A. Audisio, D. Papamichael // Nat. Rev. Gastroenterol. Hepatol. – 2012. – Vol. 9, № 12. – P. 716 – 725.

[6] Boman, B.M. Human colon cancer stem cells: a new paradigm in gastrointestinal oncology / B.M. Boman, E. Huang // J. Clin. Oncol. – 2008. – Vol. 26. – P. 2828–2838.

[7] Brabletz, T. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment / T. Brabletz [et al.] // Proc. Nat. Acad. Sci. USA. – 2012. – Vol. 98. – P. 10356–10361.

[8] Bray, F. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries / F. Bray [et al.] // CA: a cancer journal for clinicians. – 2018. – Vol. 68. – № 6. – С. 394–424.

[9] Ferrand, F., Impact of primary tumor resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy / F. Ferrand [et al.] // Eur. J. Cancer. – 2013. – Vol. 49, № 1. – P. 90–97.

[10] R iv ard, J .D . C yt oredu c tio n an d he at ed i nt ra pe ri t one al chemotherapy for colorectal cancer: are we excluding patients who may benefit? / J.D. Rivard [et al.] // J. Surg. Oncol. – 2014. – Vol. 109, № 2. – P. 104–109.

RIGHTS & PERMISSIONS

Sazonov A.A.